Company
Avilar Therapeutics
| Industry | biopharmaceutical company focused on extracellular protein degradation, increased Seed funding to $75M |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Avilar Therapeutics | Seed | 2023-02-16 |
Company
| Industry | biopharmaceutical company focused on extracellular protein degradation, increased Seed funding to $75M |
|---|
| Company | Round | Date |
|---|---|---|
| Avilar Therapeutics | Seed | 2023-02-16 |